Wassim Fares
Geen lopende functies
Profiel
Wassim Fares worked as a Senior Medical Director at Janssen Pharmaceuticals, Inc. and as a Chief Medical Officer at Bellerophon Therapeutics, Inc. He received a graduate degree from The University of North Carolina at Chapel Hill and undergraduate and doctorate degrees from the American University of Beirut.
Eerdere bekende functies van Wassim Fares
| Bedrijven | Functie | Einde |
|---|---|---|
| BELLEROPHON THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Wassim Fares
| American University of Beirut | Doctorate Degree |
| The University of North Carolina at Chapel Hill | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| BELLEROPHON THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
